JP2000512971A - 新規なミネラル類とその製造及び使用方法 - Google Patents
新規なミネラル類とその製造及び使用方法Info
- Publication number
- JP2000512971A JP2000512971A JP10534463A JP53446398A JP2000512971A JP 2000512971 A JP2000512971 A JP 2000512971A JP 10534463 A JP10534463 A JP 10534463A JP 53446398 A JP53446398 A JP 53446398A JP 2000512971 A JP2000512971 A JP 2000512971A
- Authority
- JP
- Japan
- Prior art keywords
- calcium phosphate
- solution
- reaction
- precursor
- anion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 32
- 229910052500 inorganic mineral Inorganic materials 0.000 title description 84
- 239000011707 mineral Substances 0.000 title description 84
- 239000000243 solution Substances 0.000 claims abstract description 82
- 238000000034 method Methods 0.000 claims abstract description 63
- -1 oxoacid anions Chemical class 0.000 claims abstract description 38
- 150000003839 salts Chemical class 0.000 claims abstract description 31
- 229910052751 metal Inorganic materials 0.000 claims abstract description 28
- 150000001768 cations Chemical class 0.000 claims abstract description 23
- 239000002184 metal Substances 0.000 claims abstract description 22
- 150000001450 anions Chemical class 0.000 claims abstract description 21
- 239000007864 aqueous solution Substances 0.000 claims abstract description 15
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical group [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 claims description 120
- 239000001506 calcium phosphate Substances 0.000 claims description 97
- 239000011575 calcium Substances 0.000 claims description 93
- 235000011010 calcium phosphates Nutrition 0.000 claims description 93
- 229910000389 calcium phosphate Inorganic materials 0.000 claims description 83
- 238000006243 chemical reaction Methods 0.000 claims description 78
- 239000002243 precursor Substances 0.000 claims description 60
- 238000010438 heat treatment Methods 0.000 claims description 58
- 239000000203 mixture Substances 0.000 claims description 38
- 239000000463 material Substances 0.000 claims description 34
- 239000004568 cement Substances 0.000 claims description 26
- 229910052791 calcium Inorganic materials 0.000 claims description 25
- 239000007800 oxidant agent Substances 0.000 claims description 23
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 22
- 239000000047 product Substances 0.000 claims description 20
- 210000000988 bone and bone Anatomy 0.000 claims description 14
- 239000011574 phosphorus Substances 0.000 claims description 13
- 229910052698 phosphorus Inorganic materials 0.000 claims description 13
- 239000002244 precipitate Substances 0.000 claims description 13
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 10
- NHNBFGGVMKEFGY-UHFFFAOYSA-N nitrate group Chemical group [N+](=O)([O-])[O-] NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 claims description 10
- 229910002651 NO3 Inorganic materials 0.000 claims description 9
- ZCCIPPOKBCJFDN-UHFFFAOYSA-N calcium nitrate Chemical compound [Ca+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O ZCCIPPOKBCJFDN-UHFFFAOYSA-N 0.000 claims description 9
- 238000006479 redox reaction Methods 0.000 claims description 9
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical group O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 claims description 8
- 238000002425 crystallisation Methods 0.000 claims description 7
- 230000008025 crystallization Effects 0.000 claims description 7
- ACVYVLVWPXVTIT-UHFFFAOYSA-M phosphinate Chemical compound [O-][PH2]=O ACVYVLVWPXVTIT-UHFFFAOYSA-M 0.000 claims description 7
- ACVYVLVWPXVTIT-UHFFFAOYSA-N phosphinic acid Chemical compound O[PH2]=O ACVYVLVWPXVTIT-UHFFFAOYSA-N 0.000 claims description 7
- 230000000975 bioactive effect Effects 0.000 claims description 5
- 229910052742 iron Inorganic materials 0.000 claims description 4
- 230000002378 acidificating effect Effects 0.000 claims description 3
- 229910052804 chromium Inorganic materials 0.000 claims description 3
- 229910052802 copper Inorganic materials 0.000 claims description 3
- 230000007547 defect Effects 0.000 claims description 3
- 150000004715 keto acids Chemical class 0.000 claims description 3
- 229910052748 manganese Inorganic materials 0.000 claims description 3
- 229910052700 potassium Inorganic materials 0.000 claims description 3
- 229910052788 barium Inorganic materials 0.000 claims description 2
- 229910052790 beryllium Inorganic materials 0.000 claims description 2
- 229910052792 caesium Inorganic materials 0.000 claims description 2
- 229910052744 lithium Inorganic materials 0.000 claims description 2
- 229910052749 magnesium Inorganic materials 0.000 claims description 2
- 229910001960 metal nitrate Inorganic materials 0.000 claims description 2
- 229910052759 nickel Inorganic materials 0.000 claims description 2
- 229910052701 rubidium Inorganic materials 0.000 claims description 2
- 229910052708 sodium Inorganic materials 0.000 claims description 2
- 229910052712 strontium Inorganic materials 0.000 claims description 2
- 229910052719 titanium Inorganic materials 0.000 claims description 2
- 230000007704 transition Effects 0.000 claims description 2
- 229910052725 zinc Inorganic materials 0.000 claims description 2
- 229910052753 mercury Inorganic materials 0.000 claims 2
- 229910052703 rhodium Inorganic materials 0.000 claims 2
- 229910052684 Cerium Inorganic materials 0.000 claims 1
- 229910052692 Dysprosium Inorganic materials 0.000 claims 1
- 229910052691 Erbium Inorganic materials 0.000 claims 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 1
- 229910052693 Europium Inorganic materials 0.000 claims 1
- 229910052688 Gadolinium Inorganic materials 0.000 claims 1
- 229910052689 Holmium Inorganic materials 0.000 claims 1
- 229910052779 Neodymium Inorganic materials 0.000 claims 1
- 229910052778 Plutonium Inorganic materials 0.000 claims 1
- 229910052777 Praseodymium Inorganic materials 0.000 claims 1
- 229910052772 Samarium Inorganic materials 0.000 claims 1
- 229910052771 Terbium Inorganic materials 0.000 claims 1
- 229910052775 Thulium Inorganic materials 0.000 claims 1
- 229910052769 Ytterbium Inorganic materials 0.000 claims 1
- 229910052782 aluminium Inorganic materials 0.000 claims 1
- 229910052785 arsenic Inorganic materials 0.000 claims 1
- 229910052793 cadmium Inorganic materials 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 229910052738 indium Inorganic materials 0.000 claims 1
- 229910052746 lanthanum Inorganic materials 0.000 claims 1
- 229910052745 lead Inorganic materials 0.000 claims 1
- 229910052758 niobium Inorganic materials 0.000 claims 1
- 229910052763 palladium Inorganic materials 0.000 claims 1
- 229910052709 silver Inorganic materials 0.000 claims 1
- 229910052718 tin Inorganic materials 0.000 claims 1
- 229910052727 yttrium Inorganic materials 0.000 claims 1
- 238000001556 precipitation Methods 0.000 abstract description 18
- 238000007254 oxidation reaction Methods 0.000 abstract description 16
- 230000003647 oxidation Effects 0.000 abstract description 14
- 239000002245 particle Substances 0.000 abstract description 10
- 230000009467 reduction Effects 0.000 abstract description 10
- 230000008569 process Effects 0.000 abstract description 8
- 238000011065 in-situ storage Methods 0.000 abstract description 5
- 150000004770 chalcogenides Chemical class 0.000 abstract description 3
- 238000007429 general method Methods 0.000 abstract description 3
- 150000004820 halides Chemical class 0.000 abstract description 3
- 235000010755 mineral Nutrition 0.000 description 83
- 229960001714 calcium phosphate Drugs 0.000 description 74
- 239000007787 solid Substances 0.000 description 68
- 239000012071 phase Substances 0.000 description 57
- 238000002441 X-ray diffraction Methods 0.000 description 53
- 239000000843 powder Substances 0.000 description 31
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 27
- 239000013078 crystal Substances 0.000 description 26
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 26
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 24
- 229910019142 PO4 Inorganic materials 0.000 description 22
- 235000021317 phosphate Nutrition 0.000 description 22
- 229960005069 calcium Drugs 0.000 description 21
- 238000010586 diagram Methods 0.000 description 19
- 239000010452 phosphate Substances 0.000 description 19
- 239000012153 distilled water Substances 0.000 description 18
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 18
- 239000003153 chemical reaction reagent Substances 0.000 description 16
- 230000015572 biosynthetic process Effects 0.000 description 15
- 238000006722 reduction reaction Methods 0.000 description 14
- 241000894007 species Species 0.000 description 14
- 238000004090 dissolution Methods 0.000 description 13
- 238000002360 preparation method Methods 0.000 description 13
- 239000011521 glass Substances 0.000 description 12
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 11
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 11
- 230000001976 improved effect Effects 0.000 description 11
- 239000005297 pyrex Substances 0.000 description 11
- 239000011541 reaction mixture Substances 0.000 description 11
- 239000000919 ceramic Substances 0.000 description 10
- 238000003756 stirring Methods 0.000 description 10
- 238000010792 warming Methods 0.000 description 10
- 239000012456 homogeneous solution Substances 0.000 description 9
- 235000011837 pasties Nutrition 0.000 description 9
- VSIIXMUUUJUKCM-UHFFFAOYSA-D pentacalcium;fluoride;triphosphate Chemical compound [F-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O VSIIXMUUUJUKCM-UHFFFAOYSA-D 0.000 description 9
- 239000000126 substance Substances 0.000 description 9
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 8
- 229910052586 apatite Inorganic materials 0.000 description 8
- 229910000392 octacalcium phosphate Inorganic materials 0.000 description 8
- YIGWVOWKHUSYER-UHFFFAOYSA-F tetracalcium;hydrogen phosphate;diphosphate Chemical compound [Ca+2].[Ca+2].[Ca+2].[Ca+2].OP([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O YIGWVOWKHUSYER-UHFFFAOYSA-F 0.000 description 8
- 235000019731 tricalcium phosphate Nutrition 0.000 description 8
- 239000011701 zinc Substances 0.000 description 8
- 239000000654 additive Substances 0.000 description 7
- 238000000576 coating method Methods 0.000 description 7
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 7
- 239000003795 chemical substances by application Substances 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 150000002500 ions Chemical class 0.000 description 6
- 235000011007 phosphoric acid Nutrition 0.000 description 6
- 239000000376 reactant Substances 0.000 description 6
- GBNXLQPMFAUCOI-UHFFFAOYSA-H tetracalcium;oxygen(2-);diphosphate Chemical compound [O-2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O GBNXLQPMFAUCOI-UHFFFAOYSA-H 0.000 description 6
- 230000009466 transformation Effects 0.000 description 6
- 238000005033 Fourier transform infrared spectroscopy Methods 0.000 description 5
- 239000012620 biological material Substances 0.000 description 5
- 238000004814 ceramic processing Methods 0.000 description 5
- 239000007795 chemical reaction product Substances 0.000 description 5
- 239000011248 coating agent Substances 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- 239000002609 medium Substances 0.000 description 5
- 230000000399 orthopedic effect Effects 0.000 description 5
- 238000005498 polishing Methods 0.000 description 5
- 238000012545 processing Methods 0.000 description 5
- ZHJGWYRLJUCMRT-UHFFFAOYSA-N 5-[6-[(4-methylpiperazin-1-yl)methyl]benzimidazol-1-yl]-3-[1-[2-(trifluoromethyl)phenyl]ethoxy]thiophene-2-carboxamide Chemical compound C=1C=CC=C(C(F)(F)F)C=1C(C)OC(=C(S1)C(N)=O)C=C1N(C1=C2)C=NC1=CC=C2CN1CCN(C)CC1 ZHJGWYRLJUCMRT-UHFFFAOYSA-N 0.000 description 4
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 4
- 239000004698 Polyethylene Substances 0.000 description 4
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 4
- 239000003054 catalyst Substances 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 238000011049 filling Methods 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- VQVDTKCSDUNYBO-UHFFFAOYSA-N neodymium(3+);trinitrate;hexahydrate Chemical compound O.O.O.O.O.O.[Nd+3].[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O VQVDTKCSDUNYBO-UHFFFAOYSA-N 0.000 description 4
- 229920000573 polyethylene Polymers 0.000 description 4
- 230000009257 reactivity Effects 0.000 description 4
- 230000008439 repair process Effects 0.000 description 4
- 238000001228 spectrum Methods 0.000 description 4
- 239000002699 waste material Substances 0.000 description 4
- KWSLGOVYXMQPPX-UHFFFAOYSA-N 5-[3-(trifluoromethyl)phenyl]-2h-tetrazole Chemical compound FC(F)(F)C1=CC=CC(C2=NNN=N2)=C1 KWSLGOVYXMQPPX-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 3
- HECLRDQVFMWTQS-UHFFFAOYSA-N Dicyclopentadiene Chemical compound C1C2C3CC=CC3C1C=C2 HECLRDQVFMWTQS-UHFFFAOYSA-N 0.000 description 3
- 244000178870 Lavandula angustifolia Species 0.000 description 3
- 235000010663 Lavandula angustifolia Nutrition 0.000 description 3
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 3
- 239000003513 alkali Substances 0.000 description 3
- ILRRQNADMUWWFW-UHFFFAOYSA-K aluminium phosphate Chemical compound O1[Al]2OP1(=O)O2 ILRRQNADMUWWFW-UHFFFAOYSA-K 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 239000003462 bioceramic Substances 0.000 description 3
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical group [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 3
- ICSSIKVYVJQJND-UHFFFAOYSA-N calcium nitrate tetrahydrate Chemical compound O.O.O.O.[Ca+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O ICSSIKVYVJQJND-UHFFFAOYSA-N 0.000 description 3
- 239000003638 chemical reducing agent Substances 0.000 description 3
- 239000006185 dispersion Substances 0.000 description 3
- 239000000945 filler Substances 0.000 description 3
- 238000010304 firing Methods 0.000 description 3
- 239000004811 fluoropolymer Substances 0.000 description 3
- 229920002313 fluoropolymer Polymers 0.000 description 3
- 239000003517 fume Substances 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 239000001102 lavandula vera Substances 0.000 description 3
- 235000018219 lavender Nutrition 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- DZNFWGVDYGAMJB-UHFFFAOYSA-K neodymium(3+);phosphate Chemical compound [Nd+3].[O-]P([O-])([O-])=O DZNFWGVDYGAMJB-UHFFFAOYSA-K 0.000 description 3
- 229910017604 nitric acid Inorganic materials 0.000 description 3
- 239000000546 pharmaceutical excipient Substances 0.000 description 3
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 3
- OJMIONKXNSYLSR-UHFFFAOYSA-N phosphorous acid Chemical compound OP(O)O OJMIONKXNSYLSR-UHFFFAOYSA-N 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- 239000002002 slurry Substances 0.000 description 3
- 229910001379 sodium hypophosphite Inorganic materials 0.000 description 3
- 239000007790 solid phase Substances 0.000 description 3
- 238000007711 solidification Methods 0.000 description 3
- 230000008023 solidification Effects 0.000 description 3
- 238000006467 substitution reaction Methods 0.000 description 3
- 229910000391 tricalcium phosphate Inorganic materials 0.000 description 3
- 229940078499 tricalcium phosphate Drugs 0.000 description 3
- QBAZWXKSCUESGU-UHFFFAOYSA-N yttrium(3+);trinitrate;hexahydrate Chemical compound O.O.O.O.O.O.[Y+3].[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O QBAZWXKSCUESGU-UHFFFAOYSA-N 0.000 description 3
- 229910000164 yttrium(III) phosphate Inorganic materials 0.000 description 3
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- IOVCWXUNBOPUCH-UHFFFAOYSA-N Nitrous acid Chemical compound ON=O IOVCWXUNBOPUCH-UHFFFAOYSA-N 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- SWCIQHXIXUMHKA-UHFFFAOYSA-N aluminum;trinitrate;nonahydrate Chemical compound O.O.O.O.O.O.O.O.O.[Al+3].[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O SWCIQHXIXUMHKA-UHFFFAOYSA-N 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 230000033558 biomineral tissue development Effects 0.000 description 2
- 230000002051 biphasic effect Effects 0.000 description 2
- 239000002639 bone cement Substances 0.000 description 2
- JUNWLZAGQLJVLR-UHFFFAOYSA-J calcium diphosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])(=O)OP([O-])([O-])=O JUNWLZAGQLJVLR-UHFFFAOYSA-J 0.000 description 2
- XAAHAAMILDNBPS-UHFFFAOYSA-L calcium hydrogenphosphate dihydrate Chemical compound O.O.[Ca+2].OP([O-])([O-])=O XAAHAAMILDNBPS-UHFFFAOYSA-L 0.000 description 2
- 229910001424 calcium ion Inorganic materials 0.000 description 2
- 239000004068 calcium phosphate ceramic Substances 0.000 description 2
- 229940043256 calcium pyrophosphate Drugs 0.000 description 2
- MMFBVFWEERQGJK-UHFFFAOYSA-N calcium;tetrahydrate Chemical compound O.O.O.O.[Ca] MMFBVFWEERQGJK-UHFFFAOYSA-N 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000012993 chemical processing Methods 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 235000019821 dicalcium diphosphate Nutrition 0.000 description 2
- NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 description 2
- RBLGLDWTCZMLRW-UHFFFAOYSA-K dicalcium phosphate dihydrate Substances O.O.[Ca+2].[Ca+2].[O-]P([O-])([O-])=O RBLGLDWTCZMLRW-UHFFFAOYSA-K 0.000 description 2
- 238000012377 drug delivery Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000010419 fine particle Substances 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 239000010437 gem Substances 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 229910000398 iron phosphate Inorganic materials 0.000 description 2
- QZRHHEURPZONJU-UHFFFAOYSA-N iron(2+) dinitrate nonahydrate Chemical compound O.O.O.O.O.O.O.O.O.[Fe+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O QZRHHEURPZONJU-UHFFFAOYSA-N 0.000 description 2
- WBJZTOZJJYAKHQ-UHFFFAOYSA-K iron(3+) phosphate Chemical compound [Fe+3].[O-]P([O-])([O-])=O WBJZTOZJJYAKHQ-UHFFFAOYSA-K 0.000 description 2
- 229910001463 metal phosphate Inorganic materials 0.000 description 2
- 230000003278 mimic effect Effects 0.000 description 2
- 150000007522 mineralic acids Chemical class 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000000877 morphologic effect Effects 0.000 description 2
- CVPJXKJISAFJDU-UHFFFAOYSA-A nonacalcium;magnesium;hydrogen phosphate;iron(2+);hexaphosphate Chemical compound [Mg+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Fe+2].OP([O-])([O-])=O.OP([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O CVPJXKJISAFJDU-UHFFFAOYSA-A 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 230000001590 oxidative effect Effects 0.000 description 2
- UXBZSSBXGPYSIL-UHFFFAOYSA-N phosphoric acid;yttrium(3+) Chemical compound [Y+3].OP(O)(O)=O UXBZSSBXGPYSIL-UHFFFAOYSA-N 0.000 description 2
- 150000003016 phosphoric acids Chemical class 0.000 description 2
- 230000002285 radioactive effect Effects 0.000 description 2
- 238000007634 remodeling Methods 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 229910001220 stainless steel Inorganic materials 0.000 description 2
- 239000010935 stainless steel Substances 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- DHCDFWKWKRSZHF-UHFFFAOYSA-L thiosulfate(2-) Chemical compound [O-]S([S-])(=O)=O DHCDFWKWKRSZHF-UHFFFAOYSA-L 0.000 description 2
- 238000000844 transformation Methods 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- 229910052591 whitlockite Inorganic materials 0.000 description 2
- ONDPHDOFVYQSGI-UHFFFAOYSA-N zinc nitrate Chemical compound [Zn+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O ONDPHDOFVYQSGI-UHFFFAOYSA-N 0.000 description 2
- LRXTYHSAJDENHV-UHFFFAOYSA-H zinc phosphate Chemical compound [Zn+2].[Zn+2].[Zn+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O LRXTYHSAJDENHV-UHFFFAOYSA-H 0.000 description 2
- 229910000165 zinc phosphate Inorganic materials 0.000 description 2
- JGPSMWXKRPZZRG-UHFFFAOYSA-N zinc;dinitrate;hexahydrate Chemical compound O.O.O.O.O.O.[Zn+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O JGPSMWXKRPZZRG-UHFFFAOYSA-N 0.000 description 2
- UBOXGVDOUJQMTN-UHFFFAOYSA-N 1,1,2-trichloroethane Chemical compound ClCC(Cl)Cl UBOXGVDOUJQMTN-UHFFFAOYSA-N 0.000 description 1
- MIDXCONKKJTLDX-UHFFFAOYSA-N 3,5-dimethylcyclopentane-1,2-dione Chemical compound CC1CC(C)C(=O)C1=O MIDXCONKKJTLDX-UHFFFAOYSA-N 0.000 description 1
- XNDZQQSKSQTQQD-UHFFFAOYSA-N 3-methylcyclohex-2-en-1-ol Chemical compound CC1=CC(O)CCC1 XNDZQQSKSQTQQD-UHFFFAOYSA-N 0.000 description 1
- 229910000619 316 stainless steel Inorganic materials 0.000 description 1
- 241000242757 Anthozoa Species 0.000 description 1
- 241000139727 Apata Species 0.000 description 1
- 229910021532 Calcite Inorganic materials 0.000 description 1
- 235000014653 Carica parviflora Nutrition 0.000 description 1
- 241000238586 Cirripedia Species 0.000 description 1
- 235000019739 Dicalciumphosphate Nutrition 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 239000005574 MCPA Substances 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- HCJWCUDNVVDOMX-UHFFFAOYSA-N OP(O)(O)=O.[SeH2] Chemical compound OP(O)(O)=O.[SeH2] HCJWCUDNVVDOMX-UHFFFAOYSA-N 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 241001474728 Satyrodes eurydice Species 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- WHKUVVPPKQRRBV-UHFFFAOYSA-N Trasan Chemical compound CC1=CC(Cl)=CC=C1OCC(O)=O WHKUVVPPKQRRBV-UHFFFAOYSA-N 0.000 description 1
- ZQBZAOZWBKABNC-UHFFFAOYSA-N [P].[Ca] Chemical compound [P].[Ca] ZQBZAOZWBKABNC-UHFFFAOYSA-N 0.000 description 1
- NHHLKCCMQXUHTD-UHFFFAOYSA-N acetic acid;calcium;hydrate Chemical compound O.[Ca].CC(O)=O NHHLKCCMQXUHTD-UHFFFAOYSA-N 0.000 description 1
- 238000003916 acid precipitation Methods 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 238000006065 biodegradation reaction Methods 0.000 description 1
- 230000036983 biotransformation Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- YYRMJZQKEFZXMX-UHFFFAOYSA-L calcium bis(dihydrogenphosphate) Chemical compound [Ca+2].OP(O)([O-])=O.OP(O)([O-])=O YYRMJZQKEFZXMX-UHFFFAOYSA-L 0.000 description 1
- 229910001382 calcium hypophosphite Inorganic materials 0.000 description 1
- 229940064002 calcium hypophosphite Drugs 0.000 description 1
- MGOXYFDUVXZGAX-UHFFFAOYSA-M calcium nitrate sodium hypophosphite Chemical compound [Na+].[Ca+2].[O-]P=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O MGOXYFDUVXZGAX-UHFFFAOYSA-M 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- ZBZJARSYCHAEND-UHFFFAOYSA-L calcium;dihydrogen phosphate;hydrate Chemical compound O.[Ca+2].OP(O)([O-])=O.OP(O)([O-])=O ZBZJARSYCHAEND-UHFFFAOYSA-L 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 235000013736 caramel Nutrition 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 125000005587 carbonate group Chemical group 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000012700 ceramic precursor Substances 0.000 description 1
- TYAVIWGEVOBWDZ-UHFFFAOYSA-K cerium(3+);phosphate Chemical compound [Ce+3].[O-]P([O-])([O-])=O TYAVIWGEVOBWDZ-UHFFFAOYSA-K 0.000 description 1
- QQZMWMKOWKGPQY-UHFFFAOYSA-N cerium(3+);trinitrate;hexahydrate Chemical compound O.O.O.O.O.O.[Ce+3].[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O QQZMWMKOWKGPQY-UHFFFAOYSA-N 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 239000013626 chemical specie Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 238000001246 colloidal dispersion Methods 0.000 description 1
- 230000000536 complexating effect Effects 0.000 description 1
- 239000008139 complexing agent Substances 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000010924 continuous production Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000013256 coordination polymer Substances 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000005115 demineralization Methods 0.000 description 1
- 210000003298 dental enamel Anatomy 0.000 description 1
- 239000004053 dental implant Substances 0.000 description 1
- 239000000551 dentifrice Substances 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000002059 diagnostic imaging Methods 0.000 description 1
- 229910000390 dicalcium phosphate Inorganic materials 0.000 description 1
- 229940038472 dicalcium phosphate Drugs 0.000 description 1
- 229940095079 dicalcium phosphate anhydrous Drugs 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- KRTSDMXIXPKRQR-UHFFFAOYSA-N dimethyl [4-(methylamino)-4-oxobut-2-en-2-yl] phosphate Chemical compound CNC(=O)C=C(C)OP(=O)(OC)OC KRTSDMXIXPKRQR-UHFFFAOYSA-N 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 1
- 235000011180 diphosphates Nutrition 0.000 description 1
- GRWZHXKQBITJKP-UHFFFAOYSA-L dithionite(2-) Chemical compound [O-]S(=O)S([O-])=O GRWZHXKQBITJKP-UHFFFAOYSA-L 0.000 description 1
- 239000002019 doping agent Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 229910052587 fluorapatite Inorganic materials 0.000 description 1
- 229940077441 fluorapatite Drugs 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 150000002222 fluorine compounds Chemical class 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000006112 glass ceramic composition Substances 0.000 description 1
- 239000002241 glass-ceramic Substances 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 239000010440 gypsum Substances 0.000 description 1
- 229910052602 gypsum Inorganic materials 0.000 description 1
- 239000008241 heterogeneous mixture Substances 0.000 description 1
- 150000004687 hexahydrates Chemical class 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 238000010335 hydrothermal treatment Methods 0.000 description 1
- 239000012216 imaging agent Substances 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- SZQUEWJRBJDHSM-UHFFFAOYSA-N iron(3+);trinitrate;nonahydrate Chemical compound O.O.O.O.O.O.O.O.O.[Fe+3].[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O SZQUEWJRBJDHSM-UHFFFAOYSA-N 0.000 description 1
- 239000000087 laser glass Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 239000004137 magnesium phosphate Substances 0.000 description 1
- 235000010994 magnesium phosphates Nutrition 0.000 description 1
- 239000011738 major mineral Substances 0.000 description 1
- 235000011963 major mineral Nutrition 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229910000150 monocalcium phosphate Inorganic materials 0.000 description 1
- 235000019691 monocalcium phosphate Nutrition 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- NZFACMUBFNPQSR-UHFFFAOYSA-K neodymium(3+);phosphate;hydrate Chemical compound O.[Nd+3].[O-]P([O-])([O-])=O NZFACMUBFNPQSR-UHFFFAOYSA-K 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 150000002823 nitrates Chemical class 0.000 description 1
- 238000006396 nitration reaction Methods 0.000 description 1
- 231100001143 noxa Toxicity 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000000771 oncological effect Effects 0.000 description 1
- 239000012788 optical film Substances 0.000 description 1
- 239000005304 optical glass Substances 0.000 description 1
- 210000002997 osteoclast Anatomy 0.000 description 1
- 230000002188 osteogenic effect Effects 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 125000005342 perphosphate group Chemical group 0.000 description 1
- 229940124531 pharmaceutical excipient Drugs 0.000 description 1
- 238000010587 phase diagram Methods 0.000 description 1
- 229940085991 phosphate ion Drugs 0.000 description 1
- AQSJGOWTSHOLKH-UHFFFAOYSA-N phosphite(3-) Chemical class [O-]P([O-])[O-] AQSJGOWTSHOLKH-UHFFFAOYSA-N 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 238000009725 powder blending Methods 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- LFULEKSKNZEWOE-UHFFFAOYSA-N propanil Chemical compound CCC(=O)NC1=CC=C(Cl)C(Cl)=C1 LFULEKSKNZEWOE-UHFFFAOYSA-N 0.000 description 1
- 239000011253 protective coating Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 229910052761 rare earth metal Inorganic materials 0.000 description 1
- 150000002910 rare earth metals Chemical class 0.000 description 1
- 239000012429 reaction media Substances 0.000 description 1
- 238000011946 reduction process Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 229910052706 scandium Inorganic materials 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- KOUDKOMXLMXFKX-UHFFFAOYSA-N sodium oxido(oxo)phosphanium hydrate Chemical compound O.[Na+].[O-][PH+]=O KOUDKOMXLMXFKX-UHFFFAOYSA-N 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 230000003381 solubilizing effect Effects 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- XIUROWKZWPIAIB-UHFFFAOYSA-N sulfotep Chemical compound CCOP(=S)(OCC)OP(=S)(OCC)OCC XIUROWKZWPIAIB-UHFFFAOYSA-N 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- CNALVHVMBXLLIY-IUCAKERBSA-N tert-butyl n-[(3s,5s)-5-methylpiperidin-3-yl]carbamate Chemical compound C[C@@H]1CNC[C@@H](NC(=O)OC(C)(C)C)C1 CNALVHVMBXLLIY-IUCAKERBSA-N 0.000 description 1
- 238000007669 thermal treatment Methods 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 229910000319 transition metal phosphate Inorganic materials 0.000 description 1
- XWKBMOUUGHARTI-UHFFFAOYSA-N tricalcium;diphosphite Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])[O-].[O-]P([O-])[O-] XWKBMOUUGHARTI-UHFFFAOYSA-N 0.000 description 1
- 239000001226 triphosphate Substances 0.000 description 1
- 235000011178 triphosphate Nutrition 0.000 description 1
- UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 description 1
- KRURGYOKPVLRHQ-UHFFFAOYSA-L trithionate(2-) Chemical compound [O-]S(=O)(=O)SS([O-])(=O)=O KRURGYOKPVLRHQ-UHFFFAOYSA-L 0.000 description 1
- 238000003828 vacuum filtration Methods 0.000 description 1
- 229910052720 vanadium Inorganic materials 0.000 description 1
- 238000013022 venting Methods 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- UXBZSSBXGPYSIL-UHFFFAOYSA-K yttrium(iii) phosphate Chemical compound [Y+3].[O-]P([O-])([O-])=O UXBZSSBXGPYSIL-UHFFFAOYSA-K 0.000 description 1
- 239000010457 zeolite Substances 0.000 description 1
- 229910000166 zirconium phosphate Inorganic materials 0.000 description 1
- LEHFSLREWWMLPU-UHFFFAOYSA-B zirconium(4+);tetraphosphate Chemical compound [Zr+4].[Zr+4].[Zr+4].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O LEHFSLREWWMLPU-UHFFFAOYSA-B 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/02—Inorganic materials
- A61L27/12—Phosphorus-containing materials, e.g. apatite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K6/00—Preparations for dentistry
- A61K6/15—Compositions characterised by their physical properties
- A61K6/17—Particle size
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K6/00—Preparations for dentistry
- A61K6/60—Preparations for dentistry comprising organic or organo-metallic additives
- A61K6/69—Medicaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K6/00—Preparations for dentistry
- A61K6/70—Preparations for dentistry comprising inorganic additives
- A61K6/71—Fillers
- A61K6/74—Fillers comprising phosphorus-containing compounds
- A61K6/75—Apatite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K6/00—Preparations for dentistry
- A61K6/70—Preparations for dentistry comprising inorganic additives
- A61K6/71—Fillers
- A61K6/77—Glass
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K6/00—Preparations for dentistry
- A61K6/70—Preparations for dentistry comprising inorganic additives
- A61K6/78—Pigments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K6/00—Preparations for dentistry
- A61K6/80—Preparations for artificial teeth, for filling teeth or for capping teeth
- A61K6/831—Preparations for artificial teeth, for filling teeth or for capping teeth comprising non-metallic elements or compounds thereof, e.g. carbon
- A61K6/833—Glass-ceramic composites
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K6/00—Preparations for dentistry
- A61K6/80—Preparations for artificial teeth, for filling teeth or for capping teeth
- A61K6/849—Preparations for artificial teeth, for filling teeth or for capping teeth comprising inorganic cements
- A61K6/864—Phosphate cements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/02—Surgical adhesives or cements; Adhesives for colostomy devices containing inorganic materials
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
- C01B25/00—Phosphorus; Compounds thereof
- C01B25/16—Oxyacids of phosphorus; Salts thereof
- C01B25/26—Phosphates
- C01B25/32—Phosphates of magnesium, calcium, strontium, or barium
- C01B25/324—Preparation from a reaction solution obtained by acidifying with an acid other than orthophosphoric acid
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
- C01B25/00—Phosphorus; Compounds thereof
- C01B25/16—Oxyacids of phosphorus; Salts thereof
- C01B25/26—Phosphates
- C01B25/36—Aluminium phosphates
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
- C01B25/00—Phosphorus; Compounds thereof
- C01B25/16—Oxyacids of phosphorus; Salts thereof
- C01B25/26—Phosphates
- C01B25/37—Phosphates of heavy metals
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
- C01B25/00—Phosphorus; Compounds thereof
- C01B25/16—Oxyacids of phosphorus; Salts thereof
- C01B25/26—Phosphates
- C01B25/37—Phosphates of heavy metals
- C01B25/375—Phosphates of heavy metals of iron
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
- A61F2310/00005—The prosthesis being constructed from a particular material
- A61F2310/00179—Ceramics or ceramic-like structures
- A61F2310/00293—Ceramics or ceramic-like structures containing a phosphorus-containing compound, e.g. apatite
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Plastic & Reconstructive Surgery (AREA)
- Ceramic Engineering (AREA)
- Engineering & Computer Science (AREA)
- Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Medicinal Chemistry (AREA)
- Transplantation (AREA)
- Materials For Medical Uses (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Oxygen, Ozone, And Oxides In General (AREA)
- Catalysts (AREA)
- Inorganic Compounds Of Heavy Metals (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Saccharide Compounds (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1. 少なくとも一種類の金属陽イオンと少なくとも一種類のオキソアニオンと の塩を製造するための方法であって: a.i. 前記金属陽イオンと; ii. 少なくとも一種類の酸化剤と; iii. 前記オキソアニオンを形成するために、前記酸化剤により酸化 可能な、少なくとも一種類の前駆体陰イオンと; の水溶液を作ることと; b. 前記酸化剤と前記前駆体陰イオンとの間に酸化−還元反応を開始させる のに有効な温度と圧力との条件下で、前記溶液を加熱することと;を含み; c. 前記反応は、少なくとも一種類のガス状生成物を発生させ;かつ前記オ キソアニオンを生じ; d. 前記塩は前記溶液から沈殿する、方法。 2. 前記塩を加熱して、それに相転移及び/または結晶化を与えるステップを さらに含む、請求項1に記載の方法。 3. 前記酸化剤は硝酸塩であり、前記ガス状生成物は酸化窒素である、請求項 1に記載の方法。 4. 前記ガス状生成物はNO2である、請求項1に記載の方法。 5. 前記塩は実質的に均一である、請求項1に記載の方法。 6. 前記塩はリン酸カルシウムである、請求項1に記載の方法。 7. 前記加熱は約250℃までの温度にして行う、請求項1に記載の方法。 8. 前記溶液はアルコールを含む、請求項1に記載の方法。 9. 前記前駆体陰イオン類の少なくとも一種類はリン含有オキソアニオンであ る、請求項1に記載の方法。 10. 少なくとも一種類の前駆体陰イオンは次亜リン酸塩である、請求項1に 記載の方法。 11. 前記金属陽イオンは前記酸化剤の一部を形成する、請求項1に記載の方 法。 12. 前記酸化剤と金属陽イオンは金属硝酸塩を含む、請求項1に記載の方法 。 13. 少なくとも一種類の前駆体陽イオンは、一価のLi、Na、K、Rb、 Cs、Cu、AgまたはHgである、請求項1に記載の方法。 14. 少なくとも一種類の前駆体陽イオンは、二価のBe、Mg、Ca、Sr 、Ba、Cr、Mn、Fe、Co、Ni、Cu、Zn、Rh、Pd、Cd、Sn 、HgまたはPbである、請求項1に記載の方法。 15. 少なくとも一種類の前駆体陽イオンは、三または四価のAl、Cr、M n、Fe、Co、Ni、Ga、As、Y、Nb、Rh、In、La、Ti、Bi 、Ac、Ce、Pr、Nd、Sm、Eu、Gd、Tb、Dy、Ho、Er、Tm 、Yb、Lu、UまたはPuである、請求項1に記載の方法。 16. 前記酸化剤は硝酸塩である、請求項1に記載の方法。 17. 少なくとも一種類の金属陽イオンはカルシウムである、請求項1に記載 の方法。 18. 前記反応は酸性条件下で維持される、請求項1に記載の方法。 19. pH約3未満で行われる、請求項1に記載の方法。 20. pH約1.5未満で行われる、請求項1に記載の方法。 21. 少なくとも一種類の金属陽イオンと少なくとも一種類のオキソアニオン との塩であって: 前記金属陽イオンと; 少なくとも一種類の酸化剤と; 前記オキソアニオンを形成するために、前記酸化剤により酸化可能な、少 なくとも一種類の前駆体陰イオンと; の水溶液を作ることと; 前記酸化剤と前記前駆体陰イオンとの間に酸化−還元反応を開始させるのに有 効な温度と圧力との条件下で、前記溶液を加熱することと;によって形成され; 前記反応は、少なくとも一種類のガス状生成物を発生させ;かつ前記オキソア ニオンを生じ; 前記塩は前記溶液から沈殿する、塩。 22. 実質的に均質な形態を有する、請求項21に記載の塩。 23. 非化学量論的組成を有する、請求項21に記載の塩。 24. 複数の金属陽イオン類から形成される、請求項21に記載の塩。 25. 生物活性及び生体適合性リン酸カルシウムであって: リンオキソ酸と硝酸カルシウムとの水溶液を作ることと; 前記オキソ酸と前記硝酸カルシウムとの間に酸化−還元反応を開始させるのに 有効な温度と圧力との条件下で、前記溶液を加熱することと;によって製造され ; 前記反応は、酸化窒素ガスを発生させ; 該リン酸カルシウムは前記溶液から沈殿する、リン酸カルシウム。 26. 約100℃を超える温度に加熱することによりさらに得られる、請求項 25に従って製追されるリン酸カルシウム。 27. 前記加熱は約700℃未満の温度にして行う、請求項26に従って製造 されるリン酸カルシウム。 28. 前記リンオキソ酸は次亜リン酸である、請求項25に記載の生物活性及 び生体適合性リン酸カルシウム。 29. 請求項25に記載の生物活性及び生体適合性リン酸カルシウムを含む、 骨欠損の修復のための生物活性セメント。 30. 薬学的に許容可能なキャリアまたは希釈剤と共に混和される、請求項2 5に記載の生物活性及び生体適合性リン酸カルシウム。 31. 重合可能な材料と共に混和される、請求項25に記載の生物活性及び生 体適合性リン酸カルシウム。
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/784,439 | 1997-01-16 | ||
| US08/784,439 US5939039A (en) | 1997-01-16 | 1997-01-16 | Methods for production of calcium phosphate |
| PCT/US1998/000527 WO1998031630A1 (en) | 1997-01-16 | 1998-01-13 | Novel minerals and methods for their production and use |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007250711A Division JP4987655B2 (ja) | 1997-01-16 | 2007-09-27 | 新規なミネラル類とその製造及び使用方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2000512971A true JP2000512971A (ja) | 2000-10-03 |
| JP4135990B2 JP4135990B2 (ja) | 2008-08-20 |
Family
ID=25132461
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP53446398A Expired - Fee Related JP4135990B2 (ja) | 1997-01-16 | 1998-01-13 | 新規なミネラル類とその製造及び使用方法 |
| JP2007250711A Expired - Fee Related JP4987655B2 (ja) | 1997-01-16 | 2007-09-27 | 新規なミネラル類とその製造及び使用方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007250711A Expired - Fee Related JP4987655B2 (ja) | 1997-01-16 | 2007-09-27 | 新規なミネラル類とその製造及び使用方法 |
Country Status (14)
| Country | Link |
|---|---|
| US (3) | US5939039A (ja) |
| EP (1) | EP0980338B1 (ja) |
| JP (2) | JP4135990B2 (ja) |
| KR (1) | KR20000070171A (ja) |
| AT (1) | ATE271523T1 (ja) |
| AU (1) | AU730352B2 (ja) |
| CA (1) | CA2278176C (ja) |
| DE (1) | DE69825156T2 (ja) |
| ES (1) | ES2226094T3 (ja) |
| IL (1) | IL130738A0 (ja) |
| PT (1) | PT980338E (ja) |
| TW (1) | TW442440B (ja) |
| WO (1) | WO1998031630A1 (ja) |
| ZA (1) | ZA9711219B (ja) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2008541968A (ja) * | 2005-06-08 | 2008-11-27 | イボクラー ビバデント アクチエンゲゼルシャフト | 歯科用ガラスセラミック |
| JP2009539744A (ja) * | 2006-06-05 | 2009-11-19 | コーニング インコーポレイテッド | ゼノタイム結晶構造を有する単相のリン酸イットリウム及びその製造方法 |
Families Citing this family (81)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5939039A (en) * | 1997-01-16 | 1999-08-17 | Orthovita, Inc. | Methods for production of calcium phosphate |
| US7157065B2 (en) * | 1998-07-16 | 2007-01-02 | Chemetall Foote Corporation | Production of lithium compounds directly from lithium containing brines |
| US6891310B2 (en) * | 1998-07-20 | 2005-05-10 | Robert W. Beckwith | Neutrino light to photon light converting matrix |
| FR2783095B1 (fr) * | 1998-09-03 | 2002-07-19 | France Etat | Dispositif piezo-sensible, son procede de fabrication et sa mise en oeuvre |
| US6383519B1 (en) * | 1999-01-26 | 2002-05-07 | Vita Special Purpose Corporation | Inorganic shaped bodies and methods for their production and use |
| US6133498A (en) * | 1999-05-05 | 2000-10-17 | The United States Of America As Represented By The United States Department Of Energy | Method for producing chemically bonded phosphate ceramics and for stabilizing contaminants encapsulated therein utilizing reducing agents |
| US7270705B2 (en) | 1999-07-14 | 2007-09-18 | Jiin-Huey Chern Lin | Method of increasing working time of tetracalcium phosphate cement paste |
| US6840995B2 (en) * | 1999-07-14 | 2005-01-11 | Calcitec, Inc. | Process for producing fast-setting, bioresorbable calcium phosphate cements |
| US6960249B2 (en) | 1999-07-14 | 2005-11-01 | Calcitec, Inc. | Tetracalcium phosphate (TTCP) having calcium phosphate whisker on surface |
| US7169373B2 (en) | 1999-07-14 | 2007-01-30 | Calcitec, Inc. | Tetracalcium phosphate (TTCP) having calcium phosphate whisker on surface and process for preparing the same |
| US7094282B2 (en) * | 2000-07-13 | 2006-08-22 | Calcitec, Inc. | Calcium phosphate cement, use and preparation thereof |
| US6458162B1 (en) | 1999-08-13 | 2002-10-01 | Vita Special Purpose Corporation | Composite shaped bodies and methods for their production and use |
| AU2001231264A1 (en) | 2000-01-31 | 2001-08-07 | Advanced Research And Technology Institute, Inc. | Composite biomaterial including anisometric calcium phosphate reinforcement particles and related methods |
| US6426114B1 (en) | 2000-05-02 | 2002-07-30 | The University Of British Columbia | Sol-gel calcium phosphate ceramic coatings and method of making same |
| US7204876B2 (en) | 2000-07-13 | 2007-04-17 | Calcitec, Inc. | Calcium phosphate cements made from (TTCP) with surface whiskers and process for preparing same |
| US7156915B2 (en) | 2000-07-13 | 2007-01-02 | Calcitec, Inc. | Tetracalcium phosphate (TTCP) with surface whiskers and method of making same |
| US7052517B2 (en) * | 2000-10-24 | 2006-05-30 | Vita Special Purpose Corporation | Delivery device for biological composites and method of preparation thereof |
| US7045125B2 (en) * | 2000-10-24 | 2006-05-16 | Vita Special Purpose Corporation | Biologically active composites and methods for their production and use |
| US6736799B1 (en) | 2000-10-24 | 2004-05-18 | Vita Licensing, Inc. | Delivery device for biological composites and method of preparation thereof |
| WO2002040963A2 (en) * | 2000-10-24 | 2002-05-23 | Vita Special Purpose Corporation | Biologically active composites and methods for their production and use |
| WO2002083194A1 (en) * | 2001-04-12 | 2002-10-24 | Therics, Inc. | Method and apparatus for engineered regenerative biostructures |
| US20050177237A1 (en) * | 2001-04-12 | 2005-08-11 | Ben Shappley | Spinal cage insert, filler piece and method of manufacturing |
| US6558779B1 (en) * | 2001-07-03 | 2003-05-06 | Agfa-Gevaert | Ink jet recording element |
| US7238203B2 (en) | 2001-12-12 | 2007-07-03 | Vita Special Purpose Corporation | Bioactive spinal implants and method of manufacture thereof |
| US7163651B2 (en) | 2004-02-19 | 2007-01-16 | Calcitec, Inc. | Method for making a porous calcium phosphate article |
| US6994726B2 (en) | 2004-05-25 | 2006-02-07 | Calcitec, Inc. | Dual function prosthetic bone implant and method for preparing the same |
| US7118705B2 (en) | 2003-08-05 | 2006-10-10 | Calcitec, Inc. | Method for making a molded calcium phosphate article |
| US8029755B2 (en) | 2003-08-06 | 2011-10-04 | Angstrom Medica | Tricalcium phosphates, their composites, implants incorporating them, and method for their production |
| US20050085922A1 (en) * | 2003-10-17 | 2005-04-21 | Shappley Ben R. | Shaped filler for implantation into a bone void and methods of manufacture and use thereof |
| EP1686934B1 (en) * | 2003-11-07 | 2020-03-18 | Vivex Biologics Group, Inc. | Injectable bone substitute |
| US7189263B2 (en) | 2004-02-03 | 2007-03-13 | Vita Special Purpose Corporation | Biocompatible bone graft material |
| US20050214194A1 (en) * | 2004-03-23 | 2005-09-29 | Absar Ahmad | Biological process for the preparation of mineral crystals using seeds |
| US9220595B2 (en) | 2004-06-23 | 2015-12-29 | Orthovita, Inc. | Shapeable bone graft substitute and instruments for delivery thereof |
| US20060110422A1 (en) * | 2004-11-19 | 2006-05-25 | Tas Ahmet C | Conversion of calcite powders into macro- and microporous calcium phosphate scaffolds for medical applications |
| US7901650B2 (en) * | 2005-06-22 | 2011-03-08 | Skeletal Kinectics, LLC | Porous beta-tricalcium phosphate and methods for producing the same |
| CN101340935B (zh) | 2005-11-14 | 2013-05-08 | 拜奥美特3i有限责任公司 | 于植入物表面上淀积纳米粒子 |
| US8303967B2 (en) * | 2006-06-29 | 2012-11-06 | Orthovita, Inc. | Bioactive bone graft substitute |
| US20080112874A1 (en) * | 2006-08-31 | 2008-05-15 | Burkes Douglas E | Method for producing calcium phosphate powders using an auto-ignition combustion synthesis reaction |
| EP2079401B1 (en) | 2006-10-24 | 2019-05-22 | Biomet 3i, LLC | Deposition of discrete nanoparticles on a nanostructured surface of an implant |
| US8178099B2 (en) | 2006-12-29 | 2012-05-15 | Osteogenex Inc. | Methods of altering bone growth by administration of sost or wise antagonist or agonist |
| JP5248848B2 (ja) * | 2007-12-11 | 2013-07-31 | 山八歯材工業株式会社 | インプラントの製造方法及び人工歯根の製造方法 |
| EP2240116B1 (en) | 2008-01-28 | 2015-07-01 | Biomet 3I, LLC | Implant surface with increased hydrophilicity |
| WO2009128076A2 (en) | 2008-04-18 | 2009-10-22 | Collplant Ltd. | Methods of generating and using procollagen |
| US8198292B2 (en) * | 2008-07-03 | 2012-06-12 | Osteogenex, Inc. | Vinpocetine and eburnamonine derivatives for promoting bone growth, treating renal damage and cancer, and devices thereof |
| WO2010019914A2 (en) * | 2008-08-14 | 2010-02-18 | The Uab Research Foundation | Anti-arrhythmia agents, methods of their use, methods for their identification, and kits thereofre |
| US8409538B2 (en) | 2008-12-04 | 2013-04-02 | Skeletal Kinetics Llc | Tricalcium phosphate coarse particle compositions and methods for making the same |
| US8673364B2 (en) * | 2009-09-28 | 2014-03-18 | Skeletal Kinetics, Llc | Rapid setting high strength calcium phosphate cements comprising cyclodextrins |
| EP2352458A4 (en) * | 2008-12-04 | 2013-08-28 | Skeletal Kinetics Llc | TRICALCIUM PHOSPHATE GROWING PARTICLE COMPOSITIONS AND METHODS OF MAKING THE SAME |
| US20110151027A1 (en) * | 2009-12-21 | 2011-06-23 | Theodore D Clineff | Strontium-doped calcium phosphate bone graft materials |
| US9144629B2 (en) | 2010-03-03 | 2015-09-29 | Novabone Products, Llc | Ionically crosslinked materials and methods for production |
| WO2015147923A1 (en) | 2010-03-03 | 2015-10-01 | Novabone Products, Llc | Kit for delivering bone grafting materials |
| CA2791716C (en) | 2010-03-03 | 2020-08-18 | Novabone Products, Llc | Devices and methods for the regeneration of bony defects |
| US8641418B2 (en) | 2010-03-29 | 2014-02-04 | Biomet 3I, Llc | Titanium nano-scale etching on an implant surface |
| US8551525B2 (en) | 2010-12-23 | 2013-10-08 | Biostructures, Llc | Bone graft materials and methods |
| WO2013142118A1 (en) | 2012-03-20 | 2013-09-26 | Biomet 3I, Llc | Surface treatment for an implant surface |
| US10207027B2 (en) | 2012-06-11 | 2019-02-19 | Globus Medical, Inc. | Bioactive bone graft substitutes |
| KR101423982B1 (ko) * | 2012-08-10 | 2014-08-13 | 서울대학교산학협력단 | 휘트록카이트 및 그 제조 방법 |
| GB201223473D0 (en) * | 2012-12-28 | 2013-02-13 | Faradion Ltd | Metal-containing compounds |
| CN105120863B (zh) | 2013-03-14 | 2021-06-04 | 奥斯特克有限公司 | 促进骨生长的烷基胺骆驼蓬碱衍生物 |
| US9539286B2 (en) | 2013-10-18 | 2017-01-10 | Globus Medical, Inc. | Bone grafts including osteogenic stem cells, and methods relating to the same |
| US9486483B2 (en) | 2013-10-18 | 2016-11-08 | Globus Medical, Inc. | Bone grafts including osteogenic stem cells, and methods relating to the same |
| US9579421B2 (en) | 2014-02-07 | 2017-02-28 | Globus Medical Inc. | Bone grafts and methods of making and using bone grafts |
| US9463264B2 (en) | 2014-02-11 | 2016-10-11 | Globus Medical, Inc. | Bone grafts and methods of making and using bone grafts |
| US10195305B2 (en) | 2015-03-24 | 2019-02-05 | Orthovita, Inc. | Bioactive flowable wash-out resistant bone graft material and method for production thereof |
| US10016529B2 (en) | 2015-06-10 | 2018-07-10 | Globus Medical, Inc. | Biomaterial compositions, implants, and methods of making the same |
| US11426489B2 (en) | 2015-06-10 | 2022-08-30 | Globus Medical, Inc. | Biomaterial compositions, implants, and methods of making the same |
| US10729548B2 (en) | 2016-05-02 | 2020-08-04 | Howmedica Osteonics Corp. | Bioactive soft tissue implant and methods of manufacture and use thereof |
| US11331191B2 (en) | 2015-08-12 | 2022-05-17 | Howmedica Osteonics Corp. | Bioactive soft tissue implant and methods of manufacture and use thereof |
| CA2938576A1 (en) | 2015-08-12 | 2017-02-12 | Howmedica Osteonics Corp. | Methods for forming scaffolds |
| RU2627403C1 (ru) * | 2016-03-03 | 2017-08-08 | Акционерное общество "Минерально-химическая компания "ЕвроХим" | Твердая фосфатная соль и способ ее получения |
| DE102017106911A1 (de) * | 2017-03-30 | 2018-10-04 | Chemische Fabrik Budenheim Kg | Verwendung von kristallwasserfreien Fe(II)-Verbindungen als Strahlungsabsorber |
| DE102017106913A1 (de) | 2017-03-30 | 2018-10-04 | Chemische Fabrik Budenheim Kg | Verfahren zur Herstellung von elektrisch leitenden Strukturen auf einem Trägermaterial |
| DE102017106912A1 (de) | 2017-03-30 | 2018-10-04 | Chemische Fabrik Budenheim Kg | Verfahren zur Herstellung von Fe(II)P / Fe(II)MetP-Verbindungen |
| EP3678602A4 (en) | 2017-09-08 | 2021-10-06 | Pioneer Surgical Technology, Inc. | DISC IMPLANTS, INSTRUMENTS AND PROCEDURES |
| JP6842170B2 (ja) * | 2017-09-28 | 2021-03-17 | 国立大学法人 岡山大学 | 生体組織接着剤の製造方法及び生体組織接着剤 |
| USD907771S1 (en) | 2017-10-09 | 2021-01-12 | Pioneer Surgical Technology, Inc. | Intervertebral implant |
| ES3004565T3 (en) | 2018-08-14 | 2025-03-12 | Ossifi Therapeutics Llc | Pyrrolo - dipyridine compounds for the treatment of bone loss |
| CN113166058A (zh) | 2018-08-14 | 2021-07-23 | 奥斯特克有限公司 | 氟β-咔啉化合物 |
| US11478557B2 (en) | 2019-07-01 | 2022-10-25 | Vivos, Inc. | Method of preparing a radioactive yttrium phosphate particle suspension |
| US11896736B2 (en) | 2020-07-13 | 2024-02-13 | Globus Medical, Inc | Biomaterial implants and methods of making the same |
| EP4059885A1 (en) | 2021-03-16 | 2022-09-21 | Studiengesellschaft Kohle mbH | Process for preparing a transition metal phosphate |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3679360A (en) * | 1970-06-26 | 1972-07-25 | Nasa | Process for the preparation of brushite crystals |
| JPS5264199A (en) * | 1975-11-21 | 1977-05-27 | Tokyo Ika Shika Daigakuchiyou | Artificial bone and dental root with sintered apatite and method of producing same |
| US4673355A (en) * | 1982-10-25 | 1987-06-16 | Farris Edward T | Solid calcium phosphate materials |
| US4612053A (en) * | 1983-10-06 | 1986-09-16 | American Dental Association Health Foundation | Combinations of sparingly soluble calcium phosphates in slurries and pastes as mineralizers and cements |
| JPS61201612A (ja) * | 1985-03-01 | 1986-09-06 | Kanto Kagaku Kk | カルシウム−リン系アパタイトの製法 |
| EP0205622B1 (en) * | 1984-12-18 | 1993-09-08 | Kanto Kagaku Kabushiki Kaisha | Calcium-phosphorus type apatite having novel properties and process for its production |
| JPS6267451A (ja) * | 1985-09-20 | 1987-03-27 | Kanto Kagaku Kk | クロマトグラフイ−用充填剤 |
| US5034352A (en) * | 1985-06-25 | 1991-07-23 | Lifecore Biomedical, Inc. | Calcium phosphate materials |
| JPH0762674B2 (ja) * | 1986-03-07 | 1995-07-05 | 株式会社高研 | クロマトグラフイ−用吸着剤、及びその製造方法、並びに該吸着剤を使用したクロマトグラフイ−カラム |
| US4891164A (en) * | 1986-08-28 | 1990-01-02 | The Standard Oil Company | Method for separating and immobilizing radioactive materials |
| JP2543685B2 (ja) * | 1986-10-31 | 1996-10-16 | 旭光学工業株式会社 | リン酸カルシウムの製造方法 |
| JP2572793B2 (ja) * | 1987-12-23 | 1997-01-16 | 株式会社神戸製鋼所 | ヒドロキシアパタイト微粒子の製造方法 |
| US4880610A (en) * | 1988-04-20 | 1989-11-14 | Norian Corporation | In situ calcium phosphate minerals--method and composition |
| US5129905A (en) * | 1988-04-20 | 1992-07-14 | Norian Corporation | Methods for in situ prepared calcium phosphate minerals |
| US5047031A (en) * | 1988-04-20 | 1991-09-10 | Norian Corporation | In situ calcium phosphate minerals method |
| US5053212A (en) * | 1988-04-20 | 1991-10-01 | Norian Corporation | Intimate mixture of calcium and phosphate sources as precursor to hydroxyapatite |
| US4849193A (en) * | 1988-05-02 | 1989-07-18 | United States Gypsum Company | Process of preparing hydroxylapatite |
| JPH0788206B2 (ja) * | 1988-12-01 | 1995-09-27 | 株式会社神戸製鋼所 | ヒドロキシアパタイト微粒子凝集体の製造方法 |
| US5322675A (en) * | 1990-11-09 | 1994-06-21 | Director-General Of Agency Of Industrial Science And Technology | Method of preparing calcium phosphate |
| DE4124898A1 (de) * | 1990-07-27 | 1992-01-30 | Osaka Cement | Mit apatit ueberzogene tetracalciumphosphat-teilchen |
| US5338356A (en) * | 1991-10-29 | 1994-08-16 | Mitsubishi Materials Corporation | Calcium phosphate granular cement and method for producing same |
| US5338334A (en) | 1992-01-16 | 1994-08-16 | Institute Of Gas Technology | Process for preparing submicron/nanosize ceramic powders from precursors incorporated within a polymeric foam |
| US5302362A (en) * | 1992-04-10 | 1994-04-12 | Uop | Crystalline microporous metallo-zinc phosphate compositions |
| JPH0798650B2 (ja) * | 1993-01-11 | 1995-10-25 | 工業技術院長 | 板状水酸アパタイトの製造方法 |
| US5522893A (en) * | 1993-03-12 | 1996-06-04 | American Dental Association Health Foundation | Calcium phosphate hydroxyapatite precursor and methods for making and using the same |
| US5525148A (en) * | 1993-09-24 | 1996-06-11 | American Dental Association Health Foundation | Self-setting calcium phosphate cements and methods for preparing and using them |
| US5496399A (en) * | 1994-08-23 | 1996-03-05 | Norian Corporation | Storage stable calcium phosphate cements |
| JPH0948702A (ja) * | 1995-08-03 | 1997-02-18 | Dainippon Toryo Co Ltd | 歯科用セメント組成物 |
| US5939039A (en) * | 1997-01-16 | 1999-08-17 | Orthovita, Inc. | Methods for production of calcium phosphate |
-
1997
- 1997-01-16 US US08/784,439 patent/US5939039A/en not_active Expired - Lifetime
- 1997-12-12 ZA ZA9711219A patent/ZA9711219B/xx unknown
- 1997-12-22 TW TW086118499A patent/TW442440B/zh not_active IP Right Cessation
-
1998
- 1998-01-13 ES ES98902492T patent/ES2226094T3/es not_active Expired - Lifetime
- 1998-01-13 IL IL13073898A patent/IL130738A0/xx unknown
- 1998-01-13 AT AT98902492T patent/ATE271523T1/de active
- 1998-01-13 WO PCT/US1998/000527 patent/WO1998031630A1/en not_active Ceased
- 1998-01-13 PT PT98902492T patent/PT980338E/pt unknown
- 1998-01-13 DE DE69825156T patent/DE69825156T2/de not_active Expired - Lifetime
- 1998-01-13 AU AU59137/98A patent/AU730352B2/en not_active Ceased
- 1998-01-13 CA CA002278176A patent/CA2278176C/en not_active Expired - Fee Related
- 1998-01-13 KR KR1019997006397A patent/KR20000070171A/ko not_active Ceased
- 1998-01-13 JP JP53446398A patent/JP4135990B2/ja not_active Expired - Fee Related
- 1998-01-13 EP EP98902492A patent/EP0980338B1/en not_active Expired - Lifetime
-
1999
- 1999-04-21 US US09/295,506 patent/US6325987B1/en not_active Expired - Lifetime
-
2001
- 2001-10-03 US US09/970,173 patent/US6969501B2/en not_active Expired - Fee Related
-
2007
- 2007-09-27 JP JP2007250711A patent/JP4987655B2/ja not_active Expired - Fee Related
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2008541968A (ja) * | 2005-06-08 | 2008-11-27 | イボクラー ビバデント アクチエンゲゼルシャフト | 歯科用ガラスセラミック |
| JP2009539744A (ja) * | 2006-06-05 | 2009-11-19 | コーニング インコーポレイテッド | ゼノタイム結晶構造を有する単相のリン酸イットリウム及びその製造方法 |
| KR101451997B1 (ko) * | 2006-06-05 | 2014-10-21 | 코닝 인코포레이티드 | 제노타임 결정 구조를 갖는 단일상 이트륨 포스페이트 및 이의 제조방법 |
Also Published As
| Publication number | Publication date |
|---|---|
| ZA9711219B (en) | 1998-06-23 |
| CA2278176A1 (en) | 1998-07-23 |
| JP2008050260A (ja) | 2008-03-06 |
| ES2226094T3 (es) | 2005-03-16 |
| JP4135990B2 (ja) | 2008-08-20 |
| JP4987655B2 (ja) | 2012-07-25 |
| DE69825156D1 (de) | 2004-08-26 |
| US6969501B2 (en) | 2005-11-29 |
| US20020039552A1 (en) | 2002-04-04 |
| TW442440B (en) | 2001-06-23 |
| IL130738A0 (en) | 2000-06-01 |
| EP0980338B1 (en) | 2004-07-21 |
| US6325987B1 (en) | 2001-12-04 |
| KR20000070171A (ko) | 2000-11-25 |
| CA2278176C (en) | 2005-04-12 |
| EP0980338A4 (en) | 2000-02-23 |
| WO1998031630A1 (en) | 1998-07-23 |
| AU5913798A (en) | 1998-08-07 |
| PT980338E (pt) | 2004-10-29 |
| ATE271523T1 (de) | 2004-08-15 |
| AU730352B2 (en) | 2001-03-08 |
| EP0980338A1 (en) | 2000-02-23 |
| US5939039A (en) | 1999-08-17 |
| DE69825156T2 (de) | 2005-07-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4987655B2 (ja) | 新規なミネラル類とその製造及び使用方法 | |
| Ginebra et al. | Setting reaction and hardening of an apatitic calcium phosphate cement | |
| Driessens et al. | Effective formulations for the preparation of calcium phosphate bone cements | |
| EP0416761B1 (en) | Formulations for in situ prepared calcium phosphate minerals | |
| US7553362B2 (en) | High strength biological cement composition and using the same | |
| JP2002535225A (ja) | 無機成形素地およびそれの製造方法および使用 | |
| Laurence et al. | Formation of hydroxyapatite in cement systems | |
| Kizalaite et al. | Dissolution–precipitation synthesis and characterization of zinc whitlockite with variable metal content | |
| Desai et al. | A self‐setting, monetite (CaHPO4) cement for skeletal repair | |
| US20030235622A1 (en) | Method of preparing alpha-and-beta-tricalcium phosphate powders | |
| Spanos et al. | Functionalization of synthetic polymers for potential use as biomaterials: selective growth of hydroxyapatite on sulphonated polysulphone | |
| Gazzano et al. | Strontium-substituted α-TCP: Structure, stability, and reactivity in solution | |
| Zeng et al. | Enhanced hydrated properties of α-tricalcium phosphate bone cement mediated by loading magnesium substituted octacalcium phosphate | |
| AU2011272740B2 (en) | Fluorapatite-forming calcium phosphate cements | |
| JPH06122510A (ja) | リン酸八カルシウムの製造方法 | |
| MXPA99006624A (en) | Novel minerals and methods for their production and use | |
| EP1473273A1 (en) | Method of preparing alpha-and beta-tricalcium phosphate powders | |
| Klipan | Low-Temperature synthesis and characterization of magnesium and manganese whitlockite | |
| Greish | Phase evolution during the low temperature formation of stoichiometric hydroxyapatite-gypsum composites | |
| Azer | Synthesis of Selenium-Incorporated Alpha-Tricalcium Phosphate and Evaluation of its Cement-Type Reactivity | |
| Desai et al. | Copyright zyxwvutsrqpon |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20070328 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20070409 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20070927 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20080325 |
|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20080603 |
|
| R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110613 Year of fee payment: 3 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120613 Year of fee payment: 4 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120613 Year of fee payment: 4 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130613 Year of fee payment: 5 |
|
| LAPS | Cancellation because of no payment of annual fees |